DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Questcor Pharmaceuticals (NASDAQ: QCOR.DL)

0.00 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

QCOR.DL $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $47.71 - $97.80
Market Cap $0.00
P/E Ratio 16.36
Dividend (Yield) $1.20 (0.0%)
Ex-Dividend Date
Dividend Pay Date
06/27/14
07/08/14
Volume 0
Average Daily Volume 0
Current FY EPS $7.19

Sector

Healthcare

Industry

Drug Makers

Questcor Pharmaceuticals (QCOR.DL) Description

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system. Website: http://www.questcor.com/

News & Commentary

Why I'm Still Avoiding Questcor

A total of seven litigations against Questcor are currently underway. Two of them - the Retrophin litigation and USAO litigation - represent very serious threats to the H.P. Acthar business model.

Greenberg on the Stock Market: Why Investigations No Longer Matter

Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick

10 best and worst S&P 500 stocks of 2014

Update: Questcor Shareholders Are The Net Gainers Of Acquisition Deal

Gulfmark Offshore (GFL) Now Added to S&P SmallCap 600 Index - Analyst Blog

Prem Watsa Buys 4 New Stocks

Retrophin CEO Under Fire for Twitter Faux Pas

Mallinckrodt Is Like Steak - Very Tasty

Paulson Bets Again On Mallinckrodt

Top Performing Funds Play Favorits

See More QCOR.DL News...

QCOR.DL's Top Competitors

QCOR.DL $0.00 (0.00%)
Current stock: QCOR.DL
JNJ $98.44 (-0.03%)
Current stock: JNJ
NVS $99.80 (1.30%)
Current stock: NVS
PFE $33.37 (-0.95%)
Current stock: PFE